Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Fortunato MorabitoGiovanni TripepiGiovanni Del PoetaFrancesca Romana MauroGianluigi RedaPaolo SportolettiLuca LaurentiMarta CosciaYair HerishanuSabrina BossioMarzia VarettoniRoberta MurruAnnalisa ChiarenzaAndrea VisentinAdalgisa CondoluciRiccardo MoiaDaniela PietrasantaGiacomo LosetoUgo ConsoliIlaria ScortechiniFrancesca Romana MauroAntonella ZucchettoHamdi Al-JanazrehErnesto VignaEnrica Antonia MartinoRamona CassinGraziella D ArrigoSara GalimbertiAngela RagoIlaria AngelettiAnnalisa BiagiIlaria Del GiudiceRiccardo BombenAntonino NeriGilberto FronzaPaola MenichiniPaola MenichiniJacopo OlivieriGiovanna CutronaDavide RossiAntonio CuneoFrancesco Di RaimondoGianluca GaidanoAaron PolliackLivio TrentinRobin FoàManlio FerrariniValter GatteiMassimo GentilePublished in: American journal of hematology (2021)